The Killian family, of Rockwall, are celebrating a record-breaking fundraising milestone with their annual Sam's Night event, ...

Deep-pocketed investors have adopted a bearish approach towards Capricor Therapeutics CAPR, and it's something market players ...

BayCare announced that it has named Kristen A. Vogl, PT, DPT, MBA, its new vice president of service lines. With more than 20 ...

SOUL VISION, a new music and wellness initiative celebrating the healing power of Soul music and the global impact of writer/producer Frank Fitzpatrick launches today with SOUL VISION, Pt. 1 ?

By squeezing Regeneron’s Eylea, eye disease drug Vabysmo has become one of the biggest growth drivers for Roche. | Despite ...

The award recognizes an individual as the absolute best in the country for his combined academic success, football performance and leadership.

RNA editing has picked up steam in recent years as a potentially safer alternative to gene editing to treat genetic diseases.

SynaptixBio, the only company licensed to commercialise a treatment for a rare but deadly disease, says late or missed diagnosis can lead to years of unnecessary suffering Oxford-based SynaptixBio, ...

The Progressive Fibrosing Interstitial Lung Disease (PF-ILD) market is currently valued at USD 4,742.2 Million in 2023 and is ...

Palliative care is defined as the support provided by a healthcare team to enhance the quality of life for individuals, their ...

Equities research analysts at Piper Sandler assumed coverage on shares of Capricor Therapeutics (NASDAQ:CAPR – Get Free Report) in a note issued to investors on Monday, Ratings reports. The firm set ...

About 500 children worldwide have received the gene therapy, including some families traveling abroad to gain access to it.